Bertagnoli Rudolf, Yue James J, Shah Rahul V, Nanieva Regina, Pfeiffer Frank, Fenk-Mayer Andrea, Kershaw Trace, Husted Daniel S
St. Elizabeth Klinikum, Spine Center, Straubing, Germany.
Spine (Phila Pa 1976). 2005 Oct 1;30(19):2230-6. doi: 10.1097/01.brs.0000182217.87660.40.
Prospective, longitudinal minimum 2-year follow-up.
To assess the efficacy and safety of the Prodisc implant in patients with disabling single-level discogenic low back pain (LBP).
The treatment of debilitating discogenic LBP has been controversial and varied. To date, a longitudinal prospective study of the treatment of single-level incapacitating discogenic LBP using the Prodisc total disc arthroplasty technique has not been described.
A prospective analysis was performed on 118 patients treated with single-level lumbar Prodisc total disc arthroplasty. Patients 18 to 60 years of age with disabling and recalcitrant discogenic LBP with or without radicular pain secondary to single-level discogenic LBP from L3 to S1 were included. Patients were assessed before surgery, and outcome measurements were after surgery administered at 3, 6, 12, and 24 months.
A total of 104 patients (88%) fulfilled all follow-up criteria. The median age of all patients was 47 years (range, 36-60 years). Statistical improvements in VAS, Oswestry, and patient satisfaction scores occurred 3 months postoperatively. These improvements were maintained at the 24-month follow-up. Radicular pain also decreased significantly. Full-time and part-time work rates increased from 10% to 35% and 3% to 24%, respectively. No additional fusion surgeries were necessary either at the affected or unaffected levels. Radiographic analysis revealed an affected disc height increase from 4 mm to 13 mm (P < 0.001) and an affected disc motion from 3 degrees to 7 degrees (P < 0.004).
Single-level Prodisc lumbar total disc arthroplasty is a safe and efficacious treatment method for debilitating lumbar discogenic LBP. Significant improvements in patient satisfaction and disability scores occurred after surgery by 3 months and were maintained at the 2-year follow-up. No device-related complications occurred. Patients with severe to moderate disc height loss as well as those with symptomatic posterior anular defects with minimal disc height loss achieve functional gains and significant pain relief. Careful and appropriate patient selection is essential in ensuring optimal surgical outcomes.
前瞻性、纵向研究,至少随访2年。
评估Prodisc植入物治疗致残性单节段椎间盘源性下腰痛(LBP)患者的疗效和安全性。
致残性椎间盘源性下腰痛的治疗一直存在争议且方法多样。迄今为止,尚未有关于使用Prodisc全椎间盘置换技术治疗单节段致残性椎间盘源性下腰痛的纵向前瞻性研究报道。
对118例行单节段腰椎Prodisc全椎间盘置换术的患者进行前瞻性分析。纳入年龄在18至60岁之间、患有致残性顽固性椎间盘源性下腰痛且伴有或不伴有因L3至S1单节段椎间盘源性下腰痛继发的根性疼痛的患者。患者在手术前接受评估,术后在3个月、6个月、12个月和24个月进行结果测量。
共有104例患者(88%)符合所有随访标准。所有患者的中位年龄为47岁(范围36 - 60岁)。术后3个月,视觉模拟评分(VAS)、Oswestry功能障碍指数和患者满意度评分有统计学意义的改善。这些改善在24个月随访时得以维持。根性疼痛也显著减轻。全职和兼职工作率分别从10%增至35%和从3%增至24%。在患侧或未患侧节段均无需进行额外的融合手术。影像学分析显示患侧椎间盘高度从4毫米增加至13毫米(P < 0.001),患侧椎间盘活动度从3度增加至7度(P < 0.004)。
单节段Prodisc腰椎全椎间盘置换术是治疗致残性腰椎间盘源性下腰痛的一种安全有效的治疗方法。术后3个月患者满意度和功能障碍评分有显著改善,并在2年随访时得以维持。未发生与器械相关的并发症。伴有严重至中度椎间盘高度丢失的患者以及伴有症状性后纵韧带缺损且椎间盘高度丢失最小的患者均实现了功能改善和显著的疼痛缓解。谨慎且合适的患者选择对于确保最佳手术效果至关重要。